Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Palatin Technologies, Inc. is a biopharmaceutical company primarily engaged in the development of melanocortin-based therapeutics. The Company’s lead product candidate,bremelanotide, is currently in Phase II clinical trials for both male and female sexual dysfunction. The Company’s internal research and development capabilities, anchored by its proprietary MIDAS technology, are fueling product development. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. To date, the Company has formed partnerships with Tyco Healthcare Mallinckrodt and King Pharmaceuticals. ( www.palatin.com )
Palatin Technologies , Inc.
4 C Cedar Brook Drive
Cranbury, NEW JERSEY 08512
USA
Tel: (609) 495-2200
Fax: (609) 495-2201